National Research Corp. (NASDAQ:NRCIB) CEO Michael D. Hays sold 1,500 shares of the company’s stock in a transaction on Tuesday, September 20th. The shares were sold at an average price of $16.28, for a total transaction of $24,420.00. Following the completion of the sale, the chief executive officer now owns 6,467,744 shares of the company’s stock, valued at approximately $105,294,872.32. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

National Research Corp. (NASDAQ:NRCIB) traded up 1.6323% during mid-day trading on Wednesday, reaching $36.1811. 236 shares of the company traded hands. The stock has a market capitalization of $876.34 million, a PE ratio of 44.4485 and a beta of 0.28. National Research Corp. has a 52-week low of $31.36 and a 52-week high of $44.60. The firm’s 50-day moving average is $33.92 and its 200 day moving average is $35.16.

National Research Corp. (NASDAQ:NRCIB) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $0.18 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.18. National Research Corp. had a net margin of 18.75% and a return on equity of 33.74%. On average, equities research analysts expect that National Research Corp. will post $0.82 earnings per share for the current year.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be given a $0.48 dividend. This represents a $1.92 annualized dividend and a yield of 5.31%. The ex-dividend date is Wednesday, September 28th. National Research Corp.’s dividend payout ratio (DPR) is 408.52%.

An institutional investor recently bought a new position in National Research Corp. stock. WCM Investment Management CA purchased a new position in National Research Corp. (NASDAQ:NRCIB) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 46,808 shares of the company’s stock, valued at approximately $1,554,000. WCM Investment Management CA owned approximately 0.19% of National Research Corp. at the end of the most recent reporting period. 2.90% of the stock is currently owned by institutional investors and hedge funds.

Separately, Zacks Investment Research upgraded shares of National Research Corp. from a “hold” rating to a “buy” rating and set a $37.00 price target for the company in a research report on Friday, August 12th.

National Research Corp. Company Profile

National Research Corp. is a business services company in the Health Care Services industry.

5 Day Chart for NASDAQ:NRCIB

Receive News & Ratings for National Research Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corp. and related companies with's FREE daily email newsletter.